Navigation Links
Prenatal Test and Miscarriage

According to the findings of a UCSF study to be published in the September 2006 issue of the journal "Obstetrics and Gynecology," the risk of miscarriage in pregnant women seeking prenatal diagnostic test to identify genetic // or chromosomal abnormalities is lower than previously believed.

Two standard tests--amniocentesis and chorionic villus sampling (CVS)--are common prenatal tests performed during the first and second trimester of pregnancy. Early testing using the CVS procedure has typically been thought to have a higher rate of miscarriage than amniocentesis. However, in a 20-year retrospective comparison study of the two procedures, researchers found that the loss rates for both procedures decreased over time.

"This is a significant finding for use as information in both patient counseling and in establishing widespread prenatal diagnostic and screening programs," said study co-author Mary E. Norton, MD, who is medical director of the Prenatal Diagnostic Center at UCSF Medical Center and associate clinical professor in the UCSF Department of Obstetrics, Gynecology and Reproductive Sciences.

Both amniocentesis and CVS are invasive diagnostic screening methods that carry a small risk of pregnancy loss. Amniocentesis requires insertion of a hollow needle through the abdominal wall and into the uterus to withdraw amniotic fluid. CVS is a biopsy procedure that involves removing a piece of tissue from the placenta. These samples are then cultured and chromosomes analyzed to determine abnormalities associated with Down syndrome and other genetic diseases such as cystic fibrosis, Tay-Sachs disease, and sickle cell disease.

CVS can be performed at an earlier gestation period (10-12 weeks) than amniocentesis (16-20 weeks), and therefore is preferred by some patients because of earlier detection of possible abnormalities, according to Norton.

The study looked at data from 9,886 CVS and 30,893 amniocentesis proce
'"/>




Page: 1 2 3

Related medicine news :

1. The Safety Of Prenatal Ultrasounds Questioned
2. More Importance To Be Given To Prenatal Nutrition
3. Prenatal exposure to air pollution causes chromosomal damage
4. Prenatal Alcohol Exposure Sets Cognitive Problems After 10 Years
5. Personal Growth and Success Dependent on Prenatal Health
6. Prenatal multivitamins reduce birth defects
7. Prenatal Multivitamins to prevent risk of Brain Tumors In Kids
8. Simple Blood Test may Replace Invasive Prenatal Tests
9. Hope for Noninvasive Prenatal Test
10. New Approach to Routine Prenatal Genetic Testing
11. Harmful Effects Of Glucocorticoids On Newborns Owing To Prenatal Exposure
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Prenatal Test and Miscarriage

(Date:12/2/2008)...G, Mich., Dec. 2 Senior...nsurance companies gathered today to,oppose effor...ss legislation,through the lame duck session of t...f life or death for many of us in Michigan," said,...igan Disability Rights,Coalition. "A vote for thi...
(Date:12/2/2008)... Appointment of enterprise soft...celerate growth in revenue and subscribers of Yugm... Minneapolis, MN (PRWEB) December 2...rvice that lets people connect and collaborate ins...nt of Vas Bhandarkar as Chief Executive Officer. ,...
(Date:12/2/2008)...UMBUS, Ohio)Rare injuries accounted for 3.5 percen...007, according to the first study to examine rare ...es. Rare injuries include eye injuries, dental inj...and heat illness, which may result in high morbidi...ng consequences. , Football was associated with ...
(Date:12/2/2008)...T, Dec. 2 United America... owns and provides comprehensive healthcare,manag...ennessee, today,announced that its Board of Direc...horizing the Company to repurchase up to $1.0 mill... program allows for the Company,s common shares to...
Breaking Medicine News(10 mins):Health News:Opposition Continues to Grow to Blues' Legislation 2Health News:Opposition Continues to Grow to Blues' Legislation 3Health News:Yugma Appoints Vas Bhandarkar as Chief Executive Officer 2Health News:Yugma Appoints Vas Bhandarkar as Chief Executive Officer 3Health News:United American Healthcare Corporation Announces Stock Repurchase Program 2
...e. According to a recent study researchers find sm...eases the risk of having a baby with a cleft lip. ...d who were interviewed when their babies were abou...t the mother’s smoking habits before and during pr...
...the first step in the path for a treatment for hum...t time they have found a successful way to deliver... Gene therapy for muscular dystrophy has been a h...a delivery method for the whole body has been a ma...
... people infected with both HIV and hepatitis C hav...eir study, patients who are treated with a newer c...to rid their bodies of HCV than those who receive ...nt because as many as 300,000 of the estimated 1 m...
...may keep your blood pressure under control. Resear...who drank between 120 milliliters and 599 millilit...46-percent decreased risk of developing hypertensi...ople who consumed more than 600 milliliters a day ...
Other Medicine News:
(Date:12/1/2008)... ENB-0040 at Children,s Hospital, Health Sciences ...Newswire/ -- Enobia Pharma, an emerging Canadian b...utics for serious bone disorders, today announced ...ram for hypophosphatasia was dosed. Enobia is inve...B-0040 for the treatment of this rare and often cr...
(Date:12/1/2008)...cember 9 at 11:00 am ET to Discuss Phase 2 Study R...Calif., Dec. 1 Sunesis...rmaceutical company focused on the development and...oday announced new data from its studies of vorelo...ted during the 50th American Society of Hematology...
(Date:11/28/2008)...re/ -- German biotech company,Partec is expanding...ng and,AIDS patient follow-up diagnostics for dev... 2.5 million patient tests have been performed wit...low" system, supporting already,more than 1 milli...n of the,Partec innovation, the average cost of E...
(Date:11/26/2008)...ANKLIN, Mass., Nov. 26 P...ced today that it has received full approval from ...s U.S. pivotal trial to study the effectiveness of...ed therapy in the prevention of Contrast-Induced N... PLC,s request to expand their investigation from ...
Breaking Medicine Technology:Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 2Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 3Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 4Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 5Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 2Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 3German Innovation for HIV/AIDS Diagnostics has Been Used 2.5 Million Times in 2008 2PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 2PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 3PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 4Advanced Life Sciences Enters Into Definitive Securities Purchase Agreements for 2420 Million with New and Existing Institutional Investors 2134 1Advanced Life Sciences Enters Into Definitive Securities Purchase Agreements for 2420 Million with New and Existing Institutional Investors 2134 2Abdominal Fat Tied to High Risk for Coronary Trouble 8051 1Abdominal Fat Tied to High Risk for Coronary Trouble 8051 2Scientists seek to assess the microbial risks in the water we drink 8047 1Scientists seek to assess the microbial risks in the water we drink 8047 2Scientists seek to assess the microbial risks in the water we drink 8047 3Building blocks of life formed on Mars 1544 1Building blocks of life formed on Mars 1544 2
...east 45% additional,reduction in patients, LDL-cho...owering therapies, CARLSBAD, Calif., May 17, 2007 ...c. announced updated results from its ongoing,Phas... homozygous,familial hypercholesterolemia (HoFH), ...t the of Cardiology Annual Scientific Session,(ACC...
... Than for Asthma,Rheumatoid Arthritis and Migrain...y three out of,four ulcerative colitis (UC) suffer...rvey say not feeling well has become a normal part...ive when it comes,to their relationship with a spo...nt) and their emotional state (82 percent). , UC p...
Other Medicine Technology:Isis Pharmaceuticals Updates Its Positive Phase 2 Data for ISIS,301012 in Familial Hypercholesterolemia Patients 2Isis Pharmaceuticals Updates Its Positive Phase 2 Data for ISIS,301012 in Familial Hypercholesterolemia Patients 3Isis Pharmaceuticals Updates Its Positive Phase 2 Data for ISIS,301012 in Familial Hypercholesterolemia Patients 4Isis Pharmaceuticals Updates Its Positive Phase 2 Data for ISIS,301012 in Familial Hypercholesterolemia Patients 5Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many,Aspects of Daily Life 2Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many,Aspects of Daily Life 3Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many,Aspects of Daily Life 4Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many,Aspects of Daily Life 5Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many,Aspects of Daily Life 6Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many,Aspects of Daily Life 7Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many,Aspects of Daily Life 8Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many,Aspects of Daily Life 9
Used for temporary internal drainage from the ureteropelvic junction to the bladder. Supplied sterile in peel-open packages. Intended for one-time use. CAUTION: Periodic evaluation is advised; C-Flex
Used for catheter or instrument introduction. The dual knobs allow the sheath to be peeled away and removed. The maximum diameter of the catheter or instrument to be introduced should be measured to
Used for antegrade placement of a safety wire guide prior to endourological procedures. Supplied sterile in peel-open packages. Intended for one-time use.
Used to establish a percutaneous tract into the renal pelvis for catheter placement or stone manipulation. Supplied sterile in peel-open packages. Intended for one-time use.
Medicine Products: